quinacrine has been researched along with clioquinol in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fedin, IF | 1 |
Jarumilinta, R; Kradolfer, F; Sackmann, W | 1 |
6 other study(ies) available for quinacrine and clioquinol
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
[The treatment of lambliasis with énteroseptol].
Topics: Adolescent; Adult; Child; Child, Preschool; Clioquinol; Female; Giardiasis; Humans; Male; Quinacrine | 1966 |
The amoebicidal, trichomonicidal, and antibacterial effects of niridazole in laboratory animals.
Topics: Amebiasis; Amebicides; Amoeba; Animals; Anthelmintics; Antimony; Antiprotozoal Agents; Chloroquine; Clioquinol; Cricetinae; Dysentery, Bacillary; Emetine; Enterobacteriaceae Infections; Furazolidone; Imidazoles; Intestinal Diseases, Parasitic; Liver Abscess, Amebic; Metronidazole; Mice; Quinacrine; Salmonella Infections; Sulfonamides; Sulfones; Tartrates; Tetracycline; Thiazoles; Trichomonas Infections | 1969 |